AIM ImmunoTech, Inc. (AIM)

0.595 +0.04 (+8.18%) USD  |  NYAM  |  Apr 02, 16:00
0.58 -0.02 (-2.52%) After-Hours: 20:00
More

AIM ImmunoTech EBIT (% of Annual Revenues)

EBIT (% of Annual Revenues) Chart

View EBIT (% of Annual Revenues) for AIM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBIT (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBIT Definition

View EBIT Definition
Start Trial

EBIT is an acronym for earnings before interest and taxes.

Read full definition.

EBIT (% of Annual Revenues) Range, Past 5 Years

View EBIT (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBIT (% of Annual Revenues) Benchmarks

View EBIT (% of Annual Revenues) Benchmarks
Start Trial
Agenus, Inc. Upgrade
Curis, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Windtree Therapeutics, Inc. --
Viskase Holdings, Inc. Upgrade